Appointment booking for Dr. David Feldmar, MD is currently not available.Dr. David Feldmar, MD has not yet fully activated their profile on DiabetesIQ.
Dr. David Feldmar, MD (he/him) is a Surgeon in Los Angeles, CA with over 17 years of experience. What is your opinion of Dr. David Feldmar, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. David Feldmar, MD has received over $7,532 which includes payments from the following companies:
$1,727.79 from ACell, Inc.
$1,566.55 from Allergan Inc.
$1,269.62 from Merz North America, Inc.
$632.53 from Smith & Nephew, Inc.
$518.14 from Galderma Laboratories, L.P.
$406.85 from Celularity, Inc.
$220.36 from Musculoskeletal Transplant Foundation Inc.
$191.39 from TEI Medical Inc.
$145.86 from Bovie Medical Corporation
$124.42 from Stryker Corporation
$124.15 from Osiris Therapeutics Inc.
$123.84 from Celularity Functional Regeneration, LLC
$81.85 from KCI USA, Inc
$81.79 from Misonix Inc
$66.42 from Sientra, Inc.
$36.00 from Integra LifeSciences Corporation
$33.02 from Gilead Sciences Inc
$28.50 from Tepha Inc
$24.51 from Davol Inc.
$22.69 from Cook Incorporated
Payments received by Dr. David Feldmar, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!